Evidence map›Paper›PMID 41779964›Full record

ArticleNeurology2026

Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With Multiple Sclerosis.

Kathryn C Fitzgerald, Muraleetharan Sanjayan, Blake E Dewey, Pratim Guha Niyogi, Nicole Bou Rjeily, Yasser Fadlallah, Alice Delaney, Alexandra Zambriczki Lee, Safiya Duncan, Chelsea Wyche and 3 more

Abstract read
In one paragraph

Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kathryn C FitzgeraldDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0000-0003-3137-0322
Muraleetharan SanjayanDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0009-0006-6465-0063
Blake E DeweyDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0000-0003-4554-5058
Pratim Guha NiyogiDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Nicole Bou RjeilyDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.
Yasser FadlallahDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0009-0001-6806-1841
Alice DelaneyDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.
Alexandra Zambriczki LeeDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.
Safiya DuncanDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.
Chelsea WycheDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.
Peter A CalabresiDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0000-0002-7776-6472
Vadim ZipunnikovDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.ORCID 0000-0001-9864-2420
Ellen M MowryDivision of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD; and.ORCID 0000-0003-0623-5188

Funding

Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosisR01NR018851 · NINR · JOHNS HOPKINS UNIVERSITY · PI Ellen M. Mowry · 2020 to 2026
$4.2M
NINR NIH HHS R01 NR018851
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe purpose of this study was to evaluate whether accelerometry detects subtle changes in disability in people with multiple sclerosis (PwMS). Specifically, we tested how accelerometry measures change longitudinally in PwMS and assessed how these changes translate to brain atrophy and disability worsening at the individual level.

methodsWe included PwMS aged 40 years or older with approximately annual brain MRI who wore GT9X Actigraph accelerometers every 3 months over 3 years. Accelerometry-derived indices included total and 2-hour specific activity, sedentary time, and circadian rhythm parameters. Confirmed disability worsening was characterized using the composite Expanded Disability Status Scale-plus (EDSS+), and whole-brain segmentation was performed. We modeled within-person and between-person effects using Cox (for EDSS+) and linear mixed-effects (for MRI) multivariable-adjusted models adjusted for age, sex, and body mass index that included only accelerometry measures obtained before EDSS+.

resultsAmong 238 PwMS (mean age 54.8, 29% male), 120 experienced EDSS+-confirmed progression over a mean 2.9 years (SD 1.1 years). Participants wore accelerometers an average of 7.4 times over 67 days. Total activity declined an average of 43,737 activity counts (2.0% decline per year; 95% CI -59,812 to -27,663; DISCUSSION: Within-person reductions in daytime activity patterns precede clinical disability worsening and brain atrophy in PwMS. Although results require confirmation and thresholds of and responsiveness to change need to be established, longitudinal accelerometry may offer sensitive, noninvasive biomarkers of subclinical disease.

Indexed as

BrainMultiple SclerosisAccelerometryAdultAgedAtrophyCircadian RhythmDisability EvaluationDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle Aged

Identifiers

PMID41779964
PMCPMC13280744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.